Clinical Trials on Diabetes Type 2 in United Kingdom

Total 31632 results

Pfizer

Terminated

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Type 2 Diabetes Mellitus (T2DM)

United States
Nazrat Mirza
National Center for Research Resources (NCRR); Consumer Health Foundation; Jessie...

Completed

Low Glycemic Load Diets in Latino Children at Risk for Type 2 Diabetes (COOL Kids)

Obesity | Type 2 Diabetes Mellitus

United States
Imperial College London

Completed

Optimising Consultation Summaries to Promote Good Health (ONSET)

Type1 Diabetes

United Kingdom
Sanofi

Completed

Insulin Glulisine in Type 2 Diabetic Patients (Basal Plus)

Diabetes Mellitus, Type 2

Russian Federation, United States, United Kingdom
Valeritas, Inc.
Integrated Medical Development

Completed

Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting (SIMPLE)

Type 2 Diabetes Mellitus

United States
Rivus Pharmaceuticals, Inc.

Withdrawn

Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes

Obesity | Diabete Type 2

United States
Alison Gustafson
Instacart Health; Kentucky Association of Health Plans

Completed

Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes

Hypertension | Type 2 Diabetes Mellitus

United States
Newcastle-upon-Tyne Hospitals NHS Trust
British Heart Foundation; University of Newcastle Upon-Tyne

Completed

Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)

Coronary Artery Disease | Type 2 Diabetes Mellitus

United Kingdom
Pfizer

Completed

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
University of Colorado, Denver
Children's Hospital Colorado; National Institutes of Health (NIH)

Completed

Microbiome Insulin Sensitivity Study (MISS)

Obesity | Insulin Resistance | Type2 Diabetes

United States
Ohio State University Comprehensive Cancer Center

Completed

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Malignant Solid Neoplasm | Type 2 Diabetes Mellitus | Hematopoietic and Lymphoid System Neoplasm

United States
CymaBay Therapeutics, Inc.

Terminated

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States, India
Hoffmann-La Roche

Completed

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Diabetes Mellitus Type 2

Australia, Hong Kong, Spain, United States, Mexico, Russian Federation, Guatemala, United Kingdom, Brazil
AstraZeneca

Completed

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Type 2 Diabetes Mellitus

United States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
AstraZeneca

Completed

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Mannkind Corporation

Terminated

Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Kaiser Permanente
National Institute on Aging (NIA)

Recruiting

Prepare for Your Diabetes Care

Aging | Patient Activation | Type 2 Diabetes Mellitus With Hypoglycemia

United States
Nick Giannoukakis, PhD
University of South Florida; AstraZeneca; University of Pittsburgh; National Institutes...

Completed

Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes

Type 2 Diabetes Mellitus | Insulin Resistance

United States
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide as Monotherapy

Type 2 Diabetes Mellitus

Russian Federation, Romania, United States, India, Puerto Rico
City, University of London
University College, London

Completed

Coronary Heart Disease Risk in Type 2 Diabetes (CORDIA)

Type 2 Diabetes | Coronary Heart Disease

United Kingdom
University of Liverpool
St Helens & Knowsley Teaching Hospitals NHS Trust

Not yet recruiting

Differing Completion Rates of DIABETES Education on Patient Reported Outcomes (DIABETES-PRO)

Diabetes Mellitus, Type 2 | Patient Education as Topic

United Kingdom
Novo Nordisk A/S

Completed

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Germany, Japan, Canada, United Kingdom, Denmark, United States
AstraZeneca

Completed

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
NovMetaPharma Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

United States
University of Leicester
University Hospitals, Leicester

Completed

The Effects of an 8-week Vegan Diet on TMAO Levels and Post-challenge Glucose Levels in Individuals With Dysglycaemia (PYH)

Heart Diseases | Diabetes Mellitus, Type 2

United Kingdom
Mayo Clinic
Regenerative Medicine Minnesota

Terminated

Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic Kidney Disease | Diabetic Nephropathies | Chronic Kidney Disease | Kidney Failure | Diabetic Nephropathy Type 2 | Kidney Insufficiency

United States
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN)

Diabetic Nephropathies

Hong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
vTv Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
BHV Pharma
Integrium

Completed

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes (BRID)

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus

United States
University of California, San Francisco
San Francisco Department of Public Health; San Francisco General Hospital; Sonoma...

Completed

Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes (Star-Mama)

Type 2 Diabetes Mellitus | Gestational Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Type 2 Diabetes Mellitus

United States, Spain, Canada
AstraZeneca

Completed

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus (DURATION-NEO-2)

Diabetes Type 2

United States
University of Nottingham

Recruiting

Nottingham Community Liver Biomarkers Cohort

Obesity | Type 2 Diabetes | Alcohol Use Disorder | Chronic Liver Disease | Persistently Elevated ALT

United Kingdom
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS-1)

Type 2 Diabetes Mellitus

United States, Japan, India, Puerto Rico, Mexico
The Cleveland Clinic

Completed

Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes

Obesity | Bariatric Surgery Candidate | Type2 Diabetes

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Active, not recruiting

A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes (2IQP)

Type 2 Diabetes Treated With Insulin

United States, Canada
Beacon Health System
Beacon Health Foundation; Coach Me Health

Active, not recruiting

Pilot of Virtual Health Coaching Utilizing Lifestyle for Under-Resourced Patients With Type II Diabetes

Type2 Diabetes

United States
University of Bedfordshire

Unknown

Effects of Substituting Sitting With Standing and Light Intensity Activity in Free-living Conditions on Glycaemia in Overweight and Obese South Asian Adults

Cardiovascular Diseases | Diabetes | Sedentary Lifestyle | Type 2 Diabetes | Sedentary Behavior | Cardiovascular Risk Factor

United Kingdom
FibroGen

Terminated

Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Diabetic Kidney Disease

United States
LifeScan

Completed

Remote Monitoring in Diabetes Disease Management

Type 1 Diabetes | Type 2 Diabetes

United States
George Washington University
Janssen Scientific Affairs, LLC

Completed

Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Phoenix VA Health Care System
Bristol-Myers Squibb

Completed

Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

Type 2 Diabetes Mellitus (T2DM)

United States
AstraZeneca
Parexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, Inc

Completed

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Type 2 Diabetes

United States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
Theracos

Completed

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Canada
Manchester Metropolitan University
European Society for Clinical Nutrition and Metabolism

Recruiting

Role of Fasted Exercise on Improving Cardiometabolic Health

Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2

United Kingdom
vTv Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Carmot Therapeutics, Inc.

Active, not recruiting

A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Obesity | Type2 Diabetes

United States, Mexico
University of the Pacific

Recruiting

Blood Glucose Differences Using CGMs Between the Left and Right Arm in Patients With Diabetes

Type 1 Diabetes | Type 2 Diabetes

United States
Massachusetts General Hospital

Active, not recruiting

Understanding and Optimizing Care for Young Adults With Type 1 and Type 2 Diabetes Mellitus Transitioning to Adult Care

Type 1 Diabetes | Type 2 Diabetes

United States
Eli Lilly and Company

Completed

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) (AWARD-8)

Type 2 Diabetes Mellitus

Argentina, United States, Mexico, Croatia, Austria, Romania, South Africa, Slovenia

Clinical Trials on Diabetes Type 2 in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations